Your browser doesn't support javascript.
Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand.
Wanlapakorn, Nasamon; Suntronwong, Nungruthai; Kanokudom, Sitthichai; Assawakosri, Suvichada; Nilyanimit, Pornjarim; Yorsaeng, Ritthideach; Chansaenroj, Jira; Poovorawan, Yong.
  • Wanlapakorn N; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Suntronwong N; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Kanokudom S; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Assawakosri S; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Nilyanimit P; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Yorsaeng R; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Chansaenroj J; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Poovorawan Y; Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pathog Glob Health ; 116(7): 395-397, 2022 10.
Article in English | MEDLINE | ID: covidwho-1972971
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Pathog Glob Health Year: 2022 Document Type: Article Affiliation country: 20477724.2022.2108646

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Pathog Glob Health Year: 2022 Document Type: Article Affiliation country: 20477724.2022.2108646